Georgiopoulos Georgios, Ntritsos Georgios, Stamatelopoulos Kimon, Tsioufis Costas, Aimo Alberto, Masi Stefano, Evangelou Evangelos
School of Biomedical Engineering and Imaging Sciences, King's College London, Westminster Bridge Road, London SE1 7EH, UK.
Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
Eur J Prev Cardiol. 2021 Feb 9. doi: 10.1093/eurjpc/zwab005.
Observational studies suggest elevated blood pressure (BP) as the leading risk factor for incident atrial fibrillation (AF), but whether this relationship is causal remains unknown. In this study, we used Mendelian randomization (MR) to investigate the potential causal association of BP levels with the risk of developing AF.
Genetic variants associated with the BP traits were retrieved from the International Consortium of Blood Pressure-Genome Wide Association Studies (N = 299 024). From 901 reported variants, 894 were assessed in a dedicated Genome-Wide Association Study of AF genetics, including >1 000 000 subjects of European ancestry. We used two-sample MR analyses to examine the potential causal association of systolic BP (SBP) and diastolic BP (DBP) as well as of pulse pressure (PP) with AF. MR analysis identified a potentially causal association between AF and SBP [odds ratio (OR): 1.018 per 1 mmHg increase, 95% confidence interval (CI): 1.012-1.024, P < 0.001], DBP (OR: 1.026, 95% CI: 1.016-1.035, P < 0.001), and PP (OR: 1.014, 95% CI: 1.001-1.028, P = 0.033). These findings were robust in sensitivity analyses, including the MR-Egger method and the MR pleiotropy residual sum and outlier test (MR-PRESSO). The causal relationship of BP and AF did not change when single-nucleotide polymorphisms associated with possible confounders (i.e. coronary artery disease and obesity) of the causal relationship were excluded.
The association between increased BP levels and the risk of AF is likely causal and applies for different BP indices. Independently from other risk factors, optimal BP control might represent an important therapeutic target for AF prevention in the general population.
观察性研究表明血压升高是心房颤动(AF)发生的主要危险因素,但这种关系是否为因果关系尚不清楚。在本研究中,我们使用孟德尔随机化(MR)来研究血压水平与发生AF风险之间的潜在因果关联。
从国际血压基因组全基因组关联研究联盟(N = 299024)中检索与血压性状相关的基因变异。在一项专门的AF遗传学全基因组关联研究中,对901个已报道的变异中的894个进行了评估,该研究纳入了超过100万欧洲血统的受试者。我们使用两样本MR分析来检验收缩压(SBP)、舒张压(DBP)以及脉压(PP)与AF之间的潜在因果关联。MR分析确定AF与SBP [每升高1 mmHg的比值比(OR):1.018,95%置信区间(CI):1.012 - 1.024,P < 0.001]、DBP(OR:1.026,95% CI:1.016 - 1.035,P < 0.001)和PP(OR:1.014,95% CI:1.001 - 1.028,P = 0.033)之间存在潜在因果关联。这些发现在敏感性分析中是稳健的,包括MR-Egger方法和MR多效性残差总和及离群值检验(MR-PRESSO)。当排除与因果关系可能的混杂因素(即冠状动脉疾病和肥胖)相关的单核苷酸多态性时,血压与AF的因果关系并未改变。
血压水平升高与AF风险之间的关联可能是因果性的,且适用于不同的血压指标。独立于其他危险因素,最佳血压控制可能是一般人群预防AF的重要治疗靶点。